We tested this by treating TetO-KRASG12V-transduced SCLC cells with an ERK1/2 inhibitor, SCH772984, and found that this compound rescued the suppression of NETFs after doxycycline induction (Figure 2a). Here, MAPK3 is linked to small cell lung carcinoma.